In conclusion, this study has extended the mutational and clinical spectrum of SYNJ1 associated with EO typical or atypical parkinsonism and suggests that the screening of this gene should be considered in isolated cases and in patients with a later AO. The gene discussed is SYNJ1; the disease is Parkinson disease.